Breast Cancer Research

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Breast Cancer Research is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,390 EUR. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
1465-5411 · 1465-542X
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,390 EUR
Articles in DOAJ
1482
Declared review time
12 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2015-12-02
  • MEDLINE · 1999-01-01
  • PUBMED · 2000-03-12
Indexing
DOAJ · MEDLINE · PUBMED
APC
3,390 EUR
Declared review time (DOAJ)
12 weeks
Actual review time (measured)
142 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1482

Most recent article

last month

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

5861

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

209

i10-index

3083

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2015-12-02
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
90%
ORCID iDs in current deposits
16%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
BCR
Source type
journal
NLM unique ID (PubMed)
100927353
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
Show all subjects (50)
  • Cancer Risks and Factors
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Cancer Risks and Factors
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Digital Radiography and Breast Imaging
  • Digital Radiography and Breast Imaging
  • AI in cancer detection
  • AI in cancer detection
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Advanced Breast Cancer Therapies
  • Advanced Breast Cancer Therapies
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Gene expression and cancer classification
  • Gene expression and cancer classification
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Immune cells in cancer
  • Immune cells in cancer
  • Cytokine Signaling Pathways and Interactions
  • Cytokine Signaling Pathways and Interactions
  • MRI in cancer diagnosis
  • MRI in cancer diagnosis

Keywords (DOAJ)

  • oncology
  • breast cancer

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: